Evidence map›Paper›PMID 34540722›Full record

ArticleFrontiers in cellular and infection microbiology2021

Antibiotic Resistance and Virulence Profiles of

Victoria Ballén, Yaiza Gabasa, Carlos Ratia, Raquel Ortega, Marc Tejero, Sara Soto

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 2 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 2 syntheses or guidelines pooled it, 158 citations in OpenAlex.

  1. Pooled it
  2. Pathogens (Basel, Switzerland) · 2024
    Pooled it
  3. Article
  4. Article
  5. Article
  6. Molecular Characterization and Clinical Outcomes ofChildren (Basel, Switzerland) · 2026
    Article
  7. Article
  8. Genomic Surveillance of ESBL-ProducingPathogens (Basel, Switzerland) · 2026
    Article
  9. Article
  10. Incidence of carbapenemase-resistant isolates ofNew microbes and new infections · 2026
    Article
  11. mBio · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genomic characterisation and antimicrobial resistance ofFrontiers in cellular and infection microbiology · 2026
    Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Victoria BallénISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Yaiza GabasaISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Carlos RatiaISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Raquel OrtegaISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Marc TejeroISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Sara SotoISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain.
Barcelona Institute for Global Health · ESUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Klebsiella InfectionsKlebsiella pneumoniaeAnti-Bacterial Agentsbeta-LactamasesDrug Resistance, MicrobialHumansMicrobial Sensitivity TestsVirulenceAnti-Bacterial Agentsbeta-Lactamasesantimicrobial resistancebiofilmKlebsiella pneumoniaeurinary tract infectionsvirulence

Identifiers

PMID34540722
PMCPMC8440954
OpenAlexW3198204760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.